A phase II trial of olaparib and durvalumab in metastatic BRCA wild type triple-negative breast cancer.

被引：4
|
作者：
Mitri, Zahi Ibrahim
Vuky, Jacqueline
Kemmer, Kathleen A.
Savin, Michael A.
Parmar, Swapnil
Kolodzie, Annette Kolodzie
Johnson, Brett
Williams-Belizaire, Rochelle
Gray, Joe W.
Mills, Gordon B.
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Berkeley, CA USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.TPS1111
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS1111
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer Trial
    Loap, Pierre
    Loirat, Delphine
    Berger, Frederique
    Rodrigues, Manuel
    Bazire, Louis
    Pierga, Jean-Yves
    Vincent-Salomon, Anne
    Laki, Fatima
    Boudali, Latifa
    Raizonville, Laurence
    Mosseri, Veronique
    Jochem, Anne
    Eeckhoutte, Alexandre
    Diallo, Mamadou
    Stern, Marc-Henri
    Fourquet, Alain
    Kirova, Youlia
    [J]. JAMA ONCOLOGY, 2022, 8 (12) : 1802 - 1808
  • [2] Phase II trial of RAD001 plus carboplatin in patients with triple-negative metastatic breast cancer.
    Singh, Jasmeet Chadha
    Stein, Stacy
    Volm, Matthew
    Smith, Julia Anne
    Novik, Yelena
    Speyer, James L.
    Meyers, Marlene
    Adams, Sylvia
    Omene, Coral Oghenerukevwe
    Muggia, Franco
    Schneider, Robert
    Formenti, Silvia
    Davis, Samantha
    Beardslee, Brian
    Tiersten, Amy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Phase II Trial of Brostallicin and Cisplatin in Patients with Metastatic Triple Negative Breast Cancer.
    Moreno-Aspitia, A.
    Rowland, K. M.
    Liu, H.
    Hillman, D. W.
    Stella, P. J.
    Perez, E. A.
    [J]. CANCER RESEARCH, 2011, 71
  • [4] Phase I/IB trial of eribulin and everolimus in patients with triple-negative metastatic breast cancer.
    Luu, Thehang H.
    Blanchard, Suzette
    Yim, John Hosei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] A phase II study of tivantinib (ARQ-197) for metastatic triple-negative breast cancer.
    Tolaney, Sara M.
    Guo, Hao
    Barry, William Thomas
    Larrabee, Katherine
    Brock, Jane E.
    Wagle, Nikhil
    Van Allen, Eliezer Mendel
    Paweletz, Cloud
    Ivanova, Elena
    Janne, Pasi A.
    Overmoyer, Beth
    Wright, John Joseph
    Shapiro, Geoffrey
    Winer, Eric P.
    Krop, Ian E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] NOBLE Neoadjuvant Olaparib and Durvalumab for patients with BRCA-associated TripLE Negative Breast Cancer
    Buhrer, Emanuel
    Xenophontos, Eleni
    Hamy-Petit, Anne-Sophie
    Casas-Martin, Jose
    Callens, Celine
    Meyskens, Thomas
    Poncet, Coralie
    Lanzi, Anastasia
    Brain, Etienne
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [7] Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer
    Chee Khoon Lee
    Clare Scott
    Geoffrey J. Lindeman
    Anne Hamilton
    Elizabeth Lieschke
    Emma Gibbs
    Rebecca Asher
    Heath Badger
    Robin Paterson
    Lauren Macnab
    Edmond Michael Kwan
    Prudence A. Francis
    Frances Boyle
    Michael Friedlander
    [J]. British Journal of Cancer, 2019, 120 : 279 - 285
  • [8] Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer
    Lee, Chee Khoon
    Scott, Clare
    Lindeman, Geoffrey J.
    Hamilton, Anne
    Lieschke, Elizabeth
    Gibbs, Emma
    Asher, Rebecca
    Badger, Heath
    Paterson, Robin
    Macnab, Lauren
    Kwan, Edmond Michael
    Francis, Prudence A.
    Boyle, Frances
    Friedlander, Michael
    [J]. BRITISH JOURNAL OF CANCER, 2019, 120 (03) : 279 - 285
  • [9] A Phase II Trial of Selinexor (KPT-330) for Metastatic Triple-Negative Breast Cancer
    Shafique, Michael
    IsmailKhan, Roohi
    Extermann, Martine
    Sullivan, Dan
    Goodridge, Dawn
    Boulware, David
    Hogue, Deanna
    Soliman, Hatem
    Khong, Hung
    Han, Hyo S.
    [J]. ONCOLOGIST, 2019, 24 (07): : 887 - +
  • [10] A randomized phase II trial of carboplatin with or without nivolumab in metastatic triple-negative breast cancer
    Garrido-Castro, Ana C.
    Graham, Noah
    Bi, Kevin
    Park, Jihye
    Fu, Jingxin
    Keenan, Tanya
    Richardson, Edward Thomas
    Pastorello, Ricardo
    Lange, Paulina
    Attaya, Victoria
    Wesolowski, Robert
    Sinclair, Natalie
    Lucas, Zarah
    Lo, Steve
    Tung, Nadine
    Faggen, Meredith
    Kaufman, Peter A.
    Block, Caroline C.
    Briccetti, Fred
    Toke, Madhavi
    Chen, Wendy
    Wucherpfennig, Kai
    Marx, Sascha
    Agudo, Judith
    Guerriero, Jennifer L.
    Schnitt, Stuart
    Lin, Nancy U.
    Winer, Eric P.
    Mittendorf, Elizabeth A.
    Tayob, Nabihah
    Van Allen, Eliezer
    Tolaney, Sara M.
    [J]. CANCER RESEARCH, 2022, 82 (04)
12345